Innovan en es it fr

Innovan Brand names, Innovan Analogs

Innovan Brand Names Mixture

  • No information avaliable

Innovan Chemical_Formula


Innovan RX_link

Innovan fda sheet

Innovan msds (material safety sheet)

Innovan MSDS

Innovan Synthesis Reference

No information avaliable

Innovan Molecular Weight

166.24 g/mol

Innovan Melting Point

No information avaliable

Innovan H2O Solubility

Appreciable as liquid hydrochloride salt

Innovan State


Innovan LogP


Innovan Dosage Forms

Liquid for injection

Innovan Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Innovan Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Innovan Absorption

Rapidly absorbed.

Innovan side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Innovan Patient Information

No information avaliable

Innovan Organisms Affected

Humans and other mammals